Suchergebnisse - (Subject:"*Renin-Angiotensin System")

PubPharm (5.045)

41

Partial Replacement of NaCl with KCl in Cooked Meat Could Reduce the Liver Damage Through Renin-Angiotensin System in Mice

enthalten in: Molecular nutrition & food research | 2024

von Zou, L. | Yu, X. | Xiong, J. | +2

42

Assessment of the (Pro)renin Receptor Protein Expression in Organs

enthalten in: Current issues in molecular biology | 2024

von Yang, T. | Chang, P. | Ko, Y. | +2

43

Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients

enthalten in: Medicina clinica | 2024

von Lima, F. | Muniz, F. | Meneses, G. | +9

44

Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention

enthalten in: Kidney diseases (Basel, Switzerland) | 2024

von Fukase, T. | Dohi, T. | Nishio, R. | +12

45

Cardioprotective effects of losartan and diminazene against the ischemia/reperfusion injury in hyperthyroidism rats

enthalten in: Canadian journal of physiology and pharmacology | 2024

von Pashaei, M. | Hesari, M. | Shackebaei, D. | +1

46

Neonatal Renal Failure Following Intrauterine Exposure to an Angiotensin-Converting Enzyme Inhibitor

enthalten in: Cureus | 2024

von Rodrigues, I. | Quintela, C. | Jardim, J. | +4

47

The classical and non-classical axes of renin-angiotensin system in Parkinson disease : The bright and dark side of the moon

enthalten in: Ageing research reviews | 2024

von Al-Kuraishy, H. | Al-Hamash, S. | Jabir, M. | +4

48

A Successfully Treated Case of Posterior Ischemic Optic Neuropathy That Developed during Antihypertensive Therapy for Hypertensive Emergency

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Yonezawa, Y. | Koga, K. | Higashi, Y. | +5

49

Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model

enthalten in: International immunopharmacology | 2024

von Gouveia, F. | Fonseca, C. | Silva, A. | +4

50

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA) : a randomized, placebo-controlled, phase 2/3 trial

enthalten in: EClinicalMedicine | 2024

von Lobo, S. | Plantefève, G. | Nair, G. | +48